In breast, prostate, and ovarian cancers, studies using their corresponding cancer cell lines or primary cancer cells from patients all provided evidence to support that LPS could promote production of proinflammatory cytokines from cancer cells by signaling through TLR4 and MyD88 [77,138,139]. Here, MYD88 is linked to ovarian carcinoma.